Fortitude Family Office’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$967 Hold
277
– – ﹤0.01% 2259
2026
Q2
$1.5K Buy
277
+2
+0.7% +$8 ﹤0.01% 1599
2026
Q1
$627 Hold
275
– – ﹤0.01% 1640
2025
Q4
$1.1K Buy
275
+145
+112% +$806 ﹤0.01% 1412
2025
Q3
$1.1K Hold
130
– – ﹤0.01% 1512
2025
Q2
$1.46K Buy
+130
New +$1.19K ﹤0.01% 1341

Other funds holding EVH

Fortitude Family Office's EVH Position: Q3 2026 in Review

Fortitude Family Office held its Evolent Health (EVH) position steady in Q3 2026 at 277 shares worth $967. The position accounts for ﹤0.01% of the portfolio, ranked #2259.

Fortitude Family Office first reported a position in EVH in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.5K in Q2 2026. 10 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Fortitude Family Office held 277 shares of Evolent Health worth $967 as of Q3 2026.
  • Fortitude Family Office left its Evolent Health share count unchanged in Q3 2026.
  • Evolent Health made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2259 holding.
  • Fortitude Family Office first reported a position in Evolent Health in Q2 2025 and has held it in 6 quarters since.
  • Fortitude Family Office's Evolent Health position peaked at $1.5K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.